BCYC
Bicycle Therapeutics Ltd
NASDAQ: BCYC · HEALTHCARE · BIOTECHNOLOGY
$4.72
-0.21% today
Updated 2026-04-30
Market cap
$337.89M
P/E ratio
—
P/S ratio
4.66x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $10
Volume
0.5M
Bicycle Therapeutics Ltd (BCYC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-42.80%
ROE
-31.20%
ROA
-18.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-13.51M | — | — | — |
| 2017 | $2.06M | $-16.26M | -476.02% | -787.04% | -789.27% |
| 2018 | $7.14M | $-21.85M | -190.93% | -304.74% | -306.14% |
| 2019 | $13.80M | $-30.61M | 100.00% | -190.56% | -221.78% |
| 2020 | $10.39M | $-51.01M | -219.05% | -500.10% | -490.95% |
| 2021 | $11.70M | $-66.82M | 100.00% | -560.98% | -571.25% |
| 2022 | $14.46M | $-112.72M | 100.00% | -806.56% | -779.35% |
| 2023 | $26.98M | $-180.66M | -480.13% | -704.13% | -669.72% |
| 2024 | $35.27M | $-169.03M | -390.34% | -594.96% | -479.18% |
| 2025 | $72.59M | $-218.96M | 100.00% | -340.38% | -301.66% |